AAAAAA

   
Results: 1-9 |
Results: 9
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)
Authors: Mauz-Korholz, C Junker, R Gobel, U Nowak-Gottl, U
Citation: C. Mauz-korholz et al., Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols), THROMB HAEM, 83(6), 2000, pp. 840-843
Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells
Authors: Verheyen, J Bonig, H Kim, YM Banning, U Mauz-Korholz, C Kramm, C Korholz, D
Citation: J. Verheyen et al., Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells, SC J IMMUN, 51(1), 2000, pp. 45-53
Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour
Authors: Mauz-Korholz, C Harms, D Calaminus, G Gobel, U
Citation: C. Mauz-korholz et al., Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour, LANCET, 355(9204), 2000, pp. 625-625
Molecular biology and clinical manifestation of hereditary factor VII deficiency
Authors: Herrmann, FH Wulff, K Auberger, K Aumann, V Bergmann, F Bergmann, K Bratanoff, E Franke, D Grundeis, M Kreuz, W Lenk, H Losonczy, H Maak, B Marx, G Mauz-Korholz, C Pollmann, H Serban, M Sutor, A Syrbe, G Vogel, G Weinstock, N Wenzel, E Wolf, K
Citation: Fh. Herrmann et al., Molecular biology and clinical manifestation of hereditary factor VII deficiency, SEM THROMB, 26(4), 2000, pp. 393-400
Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors
Authors: Batlle, J Lopez, MF Brackmann, HH Gaillard, S Goudemand, J Humbert, J De Moerloose, P Maass, E Mauz-Korholz, C Sultan, Y Stieltjes, N
Citation: J. Batlle et al., Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors, HAEMOPHILIA, 5(6), 1999, pp. 431-435
Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)
Authors: Klinge, J Auberger, K Auerswald, G Brackmann, HH Mauz-Korholz, C Kreuz, W
Citation: J. Klinge et al., Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH), EUR J PED, 158, 1999, pp. S162-S165
DDAVP treatment in a child with von Willebrand disease type 2M
Authors: Mauz-Korholz, C Budde, U Korholz, D Gobel, U
Citation: C. Mauz-korholz et al., DDAVP treatment in a child with von Willebrand disease type 2M, EUR J PED, 158, 1999, pp. S174-S176
Transforming growth factor-beta(1) suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes
Authors: Bonig, H Banning, U Hannen, M Kim, YM Verheyen, J Mauz-Korholz, C Korholz, D
Citation: H. Bonig et al., Transforming growth factor-beta(1) suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes, SC J IMMUN, 50(6), 1999, pp. 612-618
Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and-97 protocol
Authors: Mauz-Korholz, C Nurnberger, W Irsfeld, H Korholz, D Gobel, U
Citation: C. Mauz-korholz et al., Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and-97 protocol, KLIN PADIAT, 211(4), 1999, pp. 215-217
Risultati: 1-9 |